Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • two_st
    Junior Member
    • Oct 2013
    • 2

    #1

    Cambridge Epigenetix: R&D Bioinformatician

    Cambridge Epigenetix: R&D Bioinformatician opportunity


    We are seeking an experienced Bioinformatician to strengthen our R&D group and play an integral role in the development and implementation of our growing Epigenetics tools product portfolio.

    The successful candidate should be skilled in the analysis of complex genomic datasets and data mining to improve our understanding of our processes and products. Experience of designing experiments and manipulating datasets to enable identification of DNA biomarkers, biomarker signatures and designing biomarker panels for common diseases such as cancer, diabetes and neurodegenerative disorders is of particular interest to us.

    For more details, please see attached job description, or contact Toby Ost (R&D Manager) directly: [email protected].
    Attached Files

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Today, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
67 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
47 views
0 reactions
Last Post SEQadmin2  
Working...